Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Neoplasms, Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06060847
What this trial is testing

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

Who this might be right for
Carcinoma, HepatocellularMetabolic Syndrome
Ospedale V. Fazzi 50
Not applicableStudy completedNCT01018147
What this trial is testing

4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition

Who this might be right for
Lung Cancer
Virginia Commonwealth University 22
Not applicableLooking for participantsNCT05791149
What this trial is testing

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity

Who this might be right for
Oral Squamous Cell CarcinomaMaxillo-facial SurgeryBiomarkers+3 more
Centre Hospitalier Universitaire, Amiens 60
Testing effectiveness (Phase 2)Study completedNCT00990249
What this trial is testing

Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaAllogeneic Haematopoietic Stem Cell Transplantation+1 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)UnknownNCT05133349
What this trial is testing

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial

Who this might be right for
Advanced or Metastatic Paraganglioma/ Pheochromocytoma
Nanjing First Hospital, Nanjing Medical University 20
Testing effectiveness (Phase 2)WithdrawnNCT02033538
What this trial is testing

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Early research (Phase 1)Not Yet RecruitingNCT07057349
What this trial is testing

CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer

Who this might be right for
Metastatic CancerUnresectable Solid Tumor
Cytosite Biopharma Inc. 40
Testing effectiveness (Phase 2)UnknownNCT02639858
What this trial is testing

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Samyang Biopharmaceuticals Corporation 31
Testing effectiveness (Phase 2)Study completedNCT00887458
What this trial is testing

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Who this might be right for
Prostate Cancer
Johns Hopkins University 46
Very early researchStudy completedNCT05643248
What this trial is testing

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Who this might be right for
Multiple Myeloma
Nanexa AB 9
Large-scale testing (Phase 3)Study completedNCT01121848
What this trial is testing

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sanofi 108
Testing effectiveness (Phase 2)Ended earlyNCT00087048
What this trial is testing

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT04790448
What this trial is testing

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 37
Not applicableLooking for participantsNCT02986048
What this trial is testing

Proton Therapy Patient Registry

Who this might be right for
Treatment With Proton Beam Radiation Therapy
Case Comprehensive Cancer Center 999
Not applicableEnded earlyNCT03197948
What this trial is testing

Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Not applicableUnknownNCT06275178
What this trial is testing

Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study

Who this might be right for
Pleural EffusionPleural Effusion, MalignantFibrinous Pleuritis
China-Japan Friendship Hospital 5,000
Not applicableLooking for participantsNCT04019678
What this trial is testing

Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.

Who this might be right for
Breast Cancer
Istituto Clinico Humanitas 850
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Early research (Phase 1)Study completedNCT00006485
What this trial is testing

Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Next Page